Five-year Follow-up of Human Anti-mouse Antibody in Multitransfused HIV Negative Haemophilics Treated with a Monoclonal Purified Plasma Derived Factor VIII Concentrate

Please copy the URL and add it into your RSS Feed Reader.

Thromb Haemost 1995; 74(04): 1203
DOI: 10.1055/s-0038-1649908

Letter To The Editor

Schattauer GmbH Stuttgart

Authors

W M Smid

Department of Haematology, Division of Haemostasis and Thrombosis, University Hospital, Groningen, The Netherlands
J van der Meer

Department of Haematology, Division of Haemostasis and Thrombosis, University Hospital, Groningen, The Netherlands

Received 08 May 1995

Accepted after revision 28 June 1995

Publication Date:
09 July 2018 (online)

References
1 Davis HM, Brown SK, Nash DW, Pennetti AM, Salzman PM, Schreiber AB, Haimovich J. Lack of immune response to mouse IgG in hemophilia A patients treated with Monoclate, a monoclonal antibody affinity purified factor VIII preparation. Thromb Haemost 1990; 63: 386-391

Reference Link Ris
Thieme Connect PubMed Search in Google Scholar
2 Lusher JM. Viral safety and inhibitor development associated with monoclonal antibody purified F VIIIC. Ann Hematol 1991; 63: 138-143

Reference Link Ris
Crossref PubMed Search in Google Scholar
3 Haimovich J, Davis HM, Schreiber AB. Human anti-mouse immunoglobulins in sera of patients treated chronically with monoclonal antibody-purified factor VIII. Semin Hematol 1991; 27 suppl (Suppl. 02) 11-15

Reference Link Ris
PubMed Search in Google Scholar
4 Bray GL, Kazemi M, Liu SL, Courter S, Buckwalter C, White III G, Gomperts E. Results of foreign protein antibody ELISAs in a cohort of recombinant factor VIII treated patients. Blood 1994; 84: 65 a [abstract]

Reference Link Ris
PubMed Search in Google Scholar